Skip to content
value.today

Zura Bio Ltd

🇺🇸 La Jolla, California, USABiotechnologyFounded 2021
Total raised
$16 M
1 round on record
Latest round
$16 M
May 2023
First round on record
May 2023
Today
Went public
See the company page

Zura Bio Ltd is listed today as Zura Bio Ltd: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Zura Bio Ltd
MonthRaisedRaiseSizeInvestorsSoldFiling
Apr 2024$113 MPrivate placement after listing$50 to $250 million

Zura Bio Ltd: Private sale, Apr 2024

Investors in this round

19 investors had bought by the notice of May 6, 2024: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$113 M of $113 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$6,751,799
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Gary Whale · Executive Officer
  • Kim Davis · Executive Officer
  • Kiran Nistala · Executive Officer
  • Michael Howell · Executive Officer
  • Robert Lisicki · Executive Officer, Director
  • Verender Badial · Executive Officer
  • Amit Munshi · Director
  • Arnout Ploos van Amstel · Director
  • Jennifer Jarrett · Director
  • Neil Graham · Director
  • Parvinder Thiara · Director
  • Sandeep Kulkarni · Director
  • Someit Sidhu · Director
  • Steven Schoch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount above includes the amount, if any, that the Issuer could receive if all of the issued Warrants were exercised and is reflected in the Total Remaining to be Sold.”

Signed by Kim Davis, Chief Legal Officer. Source: SEC Form D, newest notice filed May 6, 2024. Read the notice at the SEC.

equity, optionsSEC
May 2023$16 MNo. 1$10 to $50 million

Zura Bio Ltd: Raise no. 1, May 2023

Investors in this round

21 investors had bought by the notice of May 5, 2023: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $80 M offered; $64 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
$2,399,887
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions as estimates
The company
Corporation, incorporated in Cayman Islands

People named in the notice

  • Christopher Cabell · Executive Officer
  • Gary Whale · Executive Officer
  • Kim Davis · Executive Officer
  • Michael Howell · Executive Officer
  • Someit Sidhu · Executive Officer, Director
  • Verender Badial · Executive Officer
  • Amit Munshi · Director
  • Garry Neil · Director
  • Jennifer Jarrett · Director
  • Neil Graham · Director
  • Sandeep Kulkarni · Director
  • Steven Schoch · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Chardan Capital Markets LLC · New York, New YorkSold in CA, CO, CT, FL, IL, MA, MD, NY, PA, and outside the US
  • Raymond James Financial Services, Inc. · St. Petersburg, FloridaSold in TX
  • GUGGENHEIM SECURITIES, LLC · New York, New YorkSold in CA, CO, CT, FL, IL, MA, MD, NY, PA, and outside the US

Remarks in the notice

  • On fees: “Amount includes $478,125 to be paid in connection with the initial closing, and $1,921,761.62 to be paid in connection with the second closing if and when it occurs.”
  • On the amounts: “Offering to be consummated in two tranches, with 3,750,000 shares offered for approximately $16M in gross proceeds in the first tranche, and 15,073,530 shares offered for approximately $64M in the second tranche, subject to Shareholder Approval.”

Signed by Kim Davis, Chief Legal Officer. Source: SEC Form D, newest notice filed May 5, 2023. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Zura Bio Ltd chose not to state its revenue in its newest notice of a funding round (May 2024).

    SEC Form D · May 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2024

That is all the official record says: Zura Bio Ltd has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Zura Bio Ltd are on record.

Investors#

No investor of Zura Bio Ltd is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 21 investors.

Largest shareholders today

Institutions holding Zura Bio Ltd shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Zura Bio Ltd
NameRoleNamed in
Gary WhaleExecutive officerMay 2024
Kim DavisExecutive officerMay 2024
Kiran NistalaExecutive officerMay 2024
Michael HowellExecutive officerMay 2024
Robert LisickiExecutive officerMay 2024
Verender BadialExecutive officerMay 2024
Christopher CabellExecutive officerMay 2023
Someit SidhuExecutive officerMay 2023
Amit MunshiDirectorMay 2024
Arnout Ploos van AmstelDirectorMay 2024
Jennifer JarrettDirectorMay 2024
Neil GrahamDirectorMay 2024
Parvinder ThiaraDirectorMay 2024
Robert LisickiDirectorMay 2024
Sandeep KulkarniDirectorMay 2024
Someit SidhuDirectorMay 2024
Steven SchochDirectorMay 2024
Garry NeilDirectorMay 2023

Went public since 2023. Its SEC number is that of a company listed on a stock exchange.